AHAlina Hua

Alina Hua

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Alina Hua has a total of 976 co-authors. Here are the top co-authors by number of shared publications:

  • Tevfik F. Ismail

    School of Biomedical Engineering and Imaging Sciences, King’s College London , St Thomas’ Campus, St Thomas’ Hospital, Westminster Bridge Road, London SE1 7EH

    5 shared publications
  • Marcela Paola Vizcaychipi

    Imperial College London

    3 shared publications
  • Ronak Rajani

    School of Biomedical Engineering and Imaging Sciences, King's College London; Cardiology Department, Guy's & St Thomas' NHS Foundation Trust, London, UK

    3 shared publications
  • Amedeo Chiribiri

    School of Biomedical Engineering and Imaging Sciences, King's College London

    2 shared publications
  • Angela W C Lee

    School of Biomedical Engineering and Imaging Sciences, Faculty of Life Sciences & Medicine, King's College London, St Thomas' Hospital, Westminster Bridge Rd, London SE1 7EH, United Kingdom; National Heart and Lung Institute, Imperial College London, London, United Kingdom

    2 shared publications
  • Claudia Prieto

    School of Biomedical Engineering and Imaging Sciences King's College London London UK

    2 shared publications

Latest Publications

  • Minimum by Name, Maximum by Nature: Left Atrial Volumes in Acute Myocardial Infarction

    by Jonathan R. Weir-McCall, Alina Hua

    "Just Accepted" papers have undergone full peer review and have been accepted for publication in Radiology. This article will undergo copyediting, layout, and proof review before it is published in its final version. Please note that during production of the final copyedited article, errors may be discovered which could affect the content.

  • Open Access

    Diagnostic utility of the revised Lake Louise criteria in myocarditis associated with active autoimmune rheumatic disease

    by Alina Hua, Blanca Domenech-Ximenos, Begona Lopez, Giovanni Sanna, Amedeo Chiribiri, Ronak Rajani, Michael Marber, David D'CRuz, Michelle Fernando, Tevfik F. Ismail


  • Open Access

    Is regional atrial strain a useful surrogate of regional atrial fibrosis in atrial cardiomyopathy?

    by Angela W C Lee, Charles Sillett, José Alonso Solis-Lemus, Cassia Kessler Iglesias, Luuk H G A Hopman, Alina Hua, Peter Wheen, Abdul Qayyum, Marina Strocchi, Caroline Roney, et al.

    Aims: To determine whether atrial biomechanics measured using 3D regional strain, left atrial volume (LAV), and left atrial emptying fraction (LAEF) are associated with atrial fibrosis in patients with suspected atrial cardiomyopathy. Methods and results: Cardiovascular magnetic resonance (CMR) was performed in atrial fibrillation (AF) patients (n = 47). Healthy volunteer (n = 41) and familial dilated cardiomyopathy (DCM) (n = 31) cohorts were acquired for normalization and validation, respectively. Fibrosis was quantified using late gadolinium enhancement (LGE)-CMR, and 3D regional strain was quantified using feature tracking. Machine learning classifiers were used to classify regional severe fibrosis (>30% LGE enhancement) using regional strain and global measures of atrial anatomy and function. 3D regional strain measures (peak reservoir strain or first/second strain principal component) alone were not associated with regional fibrosis (accuracies ≤ 56.0%) in the AF cohort. Severe fibrosis was found primarily in the lateral (85.1% of AF patients) and posterior (66.0%) regions. In AF patients, the classifier incorporating LAV, LAEF, and regional location was associated with severe regional fibrosis (AUC = 0.86 ± 0.06, accuracy = 79.4 ± 6.2%), while in familial DCM patients, the accuracy was lower (62.8%). Conclusion: There is a distinctive pattern of fibrosis that develops with progression of atrial cardiomyopathy, irrespective of cause. Global measures reflecting overall atrial anatomy (LAV) and function (LAEF), rather than localized regional 3D strain, were associated with severe regional fibrosis. These data suggest that regional atrial 3D strain alone is not a reliable surrogate for severe regional fibrosis.


  • Detection of Cardiac Involvement in Eosinophilic Granulomatosis With Polyangiitis (EGPA) With Multiparametric Cardiovascular Magnetic Resonance (CMR)

    by Alina Hua, Agata Sularz, Peter Wheen, Vardah Alam, Ronak Rajani, Amedeo Chiribiri, David D'CRuz, Michelle Fernando, Jaideep Dhariwal, Alexandra M. Nanzer, et al.


  • Open Access

    Anatomic, histologic, and mechanical features of the right atrium: implications for leadless atrial pacemaker implantation

    by Matthew O’cOnnor, Umberto Barbero, Daniel B Kramer, Angela Lee, Alina Hua, Tevfik Ismail, Karen P McCarthy, Steven Niederer, Christopher A Rinaldi, Vias Markides, et al.

    Leadless pacemakers (LPs) may mitigate the risk of lead failure and pocket infection related to conventional transvenous pacemakers. Atrial LPs are currently being investigated. However, the optimal and safest implant site is not known. We aimed to evaluate the right atrial (RA) anatomy and the adjacent structures using complementary analytic models [gross anatomy, cardiac magnetic resonance imaging (MRI), and computer simulation], to identify the optimal safest location to implant an atrial LP human. Wall thickness and anatomic relationships of the RA were studied in 45 formalin-preserved human hearts. In vivo RA anatomy was assessed in 100 cardiac MRI scans. Finally, 3D collision modelling was undertaken assessing for mechanical device interaction. Three potential locations for an atrial LP were identified; the right atrial appendage (RAA) base, apex, and RA lateral wall. The RAA base had a wall thickness of 2.7 ± 1.6 mm, with a low incidence of collision in virtual implants. The anteromedial recess of the RAA apex had a wall thickness of only 1.3 ± 0.4 mm and minimal interaction in the collision modelling. The RA lateral wall thickness was 2.6 ± 0.9 mm but is in close proximity to the phrenic nerve and sinoatrial artery. Based on anatomical review and 3D modelling, the best compromise for an atrial LP implantation may be the RAA base (low incidence of collision, relatively thick myocardial tissue, and without proximity to relevant epicardial structures); the anteromedial recess of the RAA apex and lateral wall are alternate sites. The mid-RAA, RA/superior vena cava junction, and septum appear to be sub-optimal fixation locations. Attitudinal view of the right atrium demonstrating the three proposed optimal locations for the implantation of an atrial leadless pacemaker; (1) anteromedial RAA apex, (2) base of the RAA, (3) right atrial lateral wall. AM, anteromedial (aspect of the RAA); CS, coronary sinus; CT, crista terminalis; EV, eustachian valve; IVC, inferior vena cava; PL, posterolateral (aspect of the RAA); RAA, right atrial appendage; RCA, right coronary artery; RVOT, right ventricular outflow tract; SB, septal bundle; SC, supraventricular crest; SVC, superior vena cava; TV, tricuspid valve.


  • The role of cardiovascular magnetic resonance in the evaluation of acute myocarditis and inflammatory cardiomyopathies in clinical practice — a comprehensive review

    by Tevfik F Ismail, Alina Hua, Sven Plein, David P D’cRuz, Michelle M A Fernando, Matthias G Friedrich, Michael J Zellweger, Assuero Giorgetti, Federico Caobelli, Philip Haaf

    Inflammatory cardiomyopathy (I-CMP) is defined as myocarditis in association with cardiac dysfunction and/or ventricular remodelling. It is characterized by inflammatory cell infiltration into the myocardium and has heterogeneous infectious and non-infectious aetiologies. A complex interplay of genetic, autoimmune, and environmental factors contributes to the substantial risk of deteriorating cardiac function, acute heart failure, and arrhythmia as well as chronic dilated cardiomyopathy and its sequelae. Multi-parametric cardiovascular magnetic resonance (CMR) imaging is sensitive to many tissue changes that occur during myocardial inflammation, regardless of its aetiology. In this review, we summarize the various aetiologies of I-CMP and illustrate how CMR contributes to non-invasive diagnosis.


  • Open Access

    Simultaneous T1, T2, and T1ρ cardiac magnetic resonance fingerprinting for contrast agent–free myocardial tissue characterization

    by Carlos Velasco, Gastão Cruz, Begoña Lavin, Alina Hua, Anastasia Fotaki, René M. Botnar, Claudia Prieto

    Purpose: To develop a simultaneous T1, T2, and T1ρ cardiac magnetic resonance fingerprinting (MRF) approach to enable comprehensive contrast agent–free myocardial tissue characterization in a single breath‐hold scan.Methods: A 2D gradient‐echo electrocardiogram‐triggered cardiac MRF sequence with low flip angles, varying magnetization preparation, and spiral trajectory was acquired at 1.5 T to encode T1, T2, and T1⍴ simultaneously. The MRF images were reconstructed using low‐rank inversion, regularized with a multicontrast patch‐based higher‐order reconstruction. Parametric maps were generated and matched in the singular value domain to extended phase graph–based dictionaries. The proposed approach was tested in phantoms and 10 healthy subjects and compared against conventional methods in terms of coefficients of determination and best fits for the phantom study, and in terms of Bland‐Altman agreement, average values and coefficient of variation of T1, T2, and T1⍴ for the healthy subjects study.Results: The T1, T2, and T1⍴ MRF values showed excellent correlation with conventional spin‐echo and clinical mapping methods in phantom studies (r2 > 0.97). Measured MRF values in myocardial tissue (mean ± SD) were 1133 ± 33 ms, 38.8 ± 3.5 ms, and 52.0 ± 4.0 ms for T1, T2 and T1⍴, respectively, against 1053 ± 47 ms, 50.4 ± 3.9 ms, and 55.9 ± 3.3 ms for T1 modified Look‐Locker inversion imaging, T2 gradient and spin echo, and T1⍴ turbo field echo, respectively.Conclusion: A cardiac MRF approach for simultaneous quantification of myocardial T1, T2, and T1ρ in a single breath‐hold MR scan of about 16 seconds has been proposed. The approach has been investigated in phantoms and healthy subjects showing good agreement with reference spin echo measurements and conventional clinical maps.


  • Optimising cardiovascular care of patients with multiple myeloma

    by Marta Fontes Oliveira, Willeke R Naaktgeboren, Alina Hua, Arjun K Ghosh, Heather Oakervee, Simon Hallam, Charlotte Manisty

    Multiple myeloma (MM) is the third most common haematological malignancy, with increasing prevalence over recent years. Advances in therapy have improved survival, changing the clinical course of MM into a chronic condition and meaning that management of comorbidities is fundamental to improve clinical outcomes. Cardiovascular (CV) events affect up to 7.5% of individuals with MM, due to a combination of patient, disease and treatment-related factors and adversely impact survival. MM typically affects older people, many with pre-existing CV risk factors or established CV disease, and the disease itself can cause renal impairment, anaemia and hyperviscosity, which exacerabate these further. Up to 15% of patients with MM develop systemic amyloidosis, with prognosis determined by the extent of cardiac involvement. Management of MM generally involves administration of multiple treatment lines over several years as disease progresses, with many drug classes associated with adverse CV effects including high rates of venous and arterial thrombosis alongside heart failure. Recommendations for holistic management of patients with MM now include routine baseline risk stratification including ECG and echocardiography and administration of thromboprophylaxis drugs for patients treated with immunomodulatory drugs. Close surveillance of high-risk patients with collaboration between haematology and cardiology is required, with prompt investigation in the event of CV symptoms, in order to identify and treat complications early. Decisions regarding discontinuation of cardiotoxic therapies should be made in a multidisciplinary setting, taking into account the severity of the complication, prognosis, expected benefits and the availability of effective alternatives.


  • High-Spatial-Resolution 3D Whole-Heart MRI T2 Mapping for Assessment of Myocarditis

    by Aurélien Bustin, Alina Hua, Giorgia Milotta, Olivier Jaubert, Reza Hajhosseiny, Tevfik F. Ismail, René M. Botnar, Claudia Prieto

    High-resolution respiratory motion compensated accelerated three-dimensional T2 mapping enables reproducible quantification of myocardial T2 times for whole-heart assessment of myocarditis in an ef... Background Clinical guidelines recommend the use of established T2 mapping sequences to detect and quantify myocarditis and edema, but T2 mapping is performed in two dimensions with limited coverag...


  • Nowhere to Hide

    by Alina Hua, Madalina Garbi, Daniel Sado, Ronak Rajani, Mohammad Albarjas